Literature DB >> 7862188

Treatment of achalasia--from whalebone to botulinum toxin.

S Cohen, H P Parkman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7862188     DOI： 10.1056/NEJM199503233321211

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Current status of achalasia management: a review on diagnosis and treatment.

Authors:  Joshua Tuason; Haruhiro Inoue
Journal:  J Gastroenterol       Date:  2017-02-10       Impact factor: 7.527

2.  A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group.

Authors:  V Annese; G Bassotti; G Coccia; M Dinelli; V D'Onofrio; G Gatto; G Leandro; A Repici; P A Testoni; A Andriulli
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

3.  Clinical applications of oro-pharyngo-oesophageal scintigraphy in the study of dysphagia.

Authors:  B Fattori; M Grosso; F Ursino; F Matteucci; V Mancini; E Rizza; V Mattone; G Mariani; A Nacci
Journal:  Acta Otorhinolaryngol Ital       Date:  2007-08       Impact factor: 2.124

4.  Assessment of Esophageal High-Resolution Impedance Manometry in Patients with Nonobstructive Dysphagia.

Authors:  Zhaoyu Liu; Jiazhi Liao; Dean Tian; Mei Liu; Zili Dan; Qin Yu
Journal:  Gastroenterol Res Pract       Date:  2018-05-02       Impact factor: 2.260
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.